Direct-to-Consumer Genetic Testing Market Deep Research Report with Forecast to 2034

The newly published report titled "Global Ready-to-Drinks (RTDs) Alcohol Market By (Product Type (Ancestry, Health And Wellness, And Entertainment), Technology (Targeted Analysis, Single Nucleotide Polymorphisms (Snps), And Whole Genome Sequencing (WGS)), Distribution Channels (Online Channels And Over-The-Counter Channels)) - By Trends, Industry Competition Analysis, Covid-19 Analysis, Revenue (US$ Billions) and Forecast Till 2034." of InsightAce Analytic Pvt. Ltd. features detailed industry analysis and an extensive study on the market, exploring its significant factors.

The global Direct-to-Consumer (DTC) Genetic Testing Market is projected to surpass USD 16.2 Billion by 2034, registering a compound annual growth rate (CAGR) of 21.2% during the forecast period.

Request For Free Sample:
https://www.insightaceanalytic.com/request-sample/1376

Genetic testing refers to medical procedures that examine alterations in genes, chromosomes, or proteins to confirm or assess the risk of genetic disorders. The DTC genetic testing model enables consumers to access these tests with minimal or no involvement from healthcare professionals. Growing public awareness regarding the availability and convenience of such testing-particularly in both developed and emerging economies-is expected to be a key driver of market growth.

The emergence of highly reliable and accurate genetic testing solutions has attracted the attention of major industry stakeholders. Leading companies such as 23andMe are leveraging targeted marketing strategies to expand their consumer base, promoting their products through both online and offline retail channels, including pharmacies.

List of Prominent Players in the Direct-to-Consumer Genetic Testing Market:
23andme Inc.
24Genetics
Ancestry.com LLC
Atlas Biomed
Color Genomics
DNAfit
Gene by Gene
Chengdu Twenty-Three Rubik's Cube Biotechnology Co., Ltd.
EasyDNA
Mapmygenome
MyHeritage Ltd.
Laboratory Corporation of America Holdings
Myriad Genetics, Inc.
Konica Minolta, Inc.
XCODE Life
Market Dynamics:
Drivers-
Traditionally, interpreting genetic test results required consultation with a qualified medical professional. However, the advent of Direct-to-Consumer (DTC) genetic testing has made such consultations optional, significantly reducing both the cost and the barriers to access for consumers. This shift has been instrumental in making genetic testing more affordable and widely accessible, especially to individuals seeking proactive insights into their health.

Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/1376

Challenges:
Despite its advantages, DTC genetic testing comes with inherent limitations. The information provided is often basic and incomplete, offering only a partial view of an individual's overall health risk. Many diseases are influenced not only by genetics but also by environmental factors, lifestyle choices, and family history, which these tests may not fully account for. Relying solely on DTC results for critical health decisions may lead to misinformed or risky choices regarding disease prevention or treatment.

Regional Trends:
North America is expected to dominate the global DTC genetic testing market throughout the forecast period, driven by growing public awareness and increasing adoption of home-based health technologies. The widespread availability of high-speed internet in urban and suburban areas across the United States and Canada supports easier access to online testing services and digital health platforms.

Additionally, the presence of a well-established regulatory framework in the region, including oversight by agencies such as the U.S. Food and Drug Administration (FDA), ensures safe usage and accountability.

Recent Developments:
• In January 2022, 23andMe Holding Co., leading consumer genetics and research firm stated that the FDA had approved a genetic health risk report on a hereditary prostate cancer marker. This is 23andMe's third 510(k) approval from the FDA (k). It also has four De Novo clearances, one of which was for the BRCA1/BRCA2 report from the company. In 2019, a third cancer-risk detection report was approved, which discovered two variations in the MUTYH gene associated with an elevated risk of colorectal cancer.
• In August 2021, Ancestry, a global pioneer in family history, announced the acquisition of Geneanet, a well-known French genealogy company. Ancestry, which has over 30 billion records from over 80 countries, assists clients in discovering new details about their family histories and relatives.

For Customization:
https://www.insightaceanalytic.com/customisation/1376

Segmentation of Direct-to-Consumer Genetic Testing Market-
By Product Type
• Ancestry
• Health and Wellness
• Entertainment
By Technology
• Targeted Analysis
• Single Nucleotide Polymorphisms (SNPs)
• Whole Genome Sequencing (WGS)
By Distribution Channel-
• Online Channel
• Over-the-Counter Channel
By Region-
• North America-
o US
o Canada
o Mexico
• Europe-
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• Asia-Pacific-
o China
o Japan
o India
o South Korea
o South East Asia
o Rest of Asia Pacific
• Latin America-
o Brazil
o Argentina
o Rest of Latin America
• Middle East & Africa-
o GCC Countries
o South Africa
o Rest of the Middle East and Africa

Get More Information:
https://www.insightaceanalytic.com/report/global-direct-to-consumer-genetic-testing-market/1376

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG

Contact us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace

This release was published on openPR.